Clinical trial registry record

Visual Remapping to Aid Reading With Field Loss

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 8, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03848663
Last registry update
July 8, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
University of Minnesota
Enrollment
108
Countries
United States
Match confidence
60%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NON RANDOMIZED · PARALLEL · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
108
Population
ALL · 16 Years
Duration
2022-02-01 to 2026-11-01
Intervention
Traditional Remapping; Personalized Remapping
Comparator
Normally sighted with artificial scotoma
Outcomes measured
Reading Speed for Individual Words — Measured during third visit- each visit is one day only and this measure refers to…; Reading Speed for Sentences — Measured during fourth visit- each visit is one day only and this measure refers to data…; Reading Speed for Natural Text Samples — Measured during fifth visit; each visit is one day only and this measure refer…; Reading error rate for Individual Words — Measured during third visit; each visit is one day only and this measure refe…; Reading error rate for Sentences — Measured during fourth visit; each visit is one day only and this measure refers to…; Reading error rate for Natural Text Samples — Measured during fifth visit; each visit is one day only and this measure…; Eye fixation quality for words — Measured during third visit; each visit is one day only and this measure refers to dat…; Eye fixation quality for sentences — Measured during fourth visit; each visit is one day only and this measure refers t…; Eye movement quality for sentences — Measured during fourth visit; Eye fixation quality for natural text samples — Measured during fifth visit; each visit is one day only and this measur…; Eye movement quality for natural text samples — Measured during fifth visit; each visit is one day only and this measur…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 60% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 60%Source terminology contains: age-related macular degeneration. Source terminology supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

vision aging
Open primary sourceExport JSON